

Green Tech makes US. Power Grid Irrelevant
There are 3,200 utilities that make up the U.S. electrical grid, the largest machine in the world. These power companies sell $400 billion worth of electricity a year, mostly derived from burning fossil fuels in centralized stations and distributed over 2.7 million miles of power lines. Read More >> Continue reading Green Tech makes US. Power Grid Irrelevant

How MMORPGs Affects your computer
Massively multiplayer online role-playing games (MMORPGs) such as “World of Warcraft” or “EVE Online” are a lot of fun, but beware: The games can also be great distribution platforms for malicious code makers.Read More >> Continue reading How MMORPGs Affects your computer

Data PRivacy Problems Kill Internet?
The Internet, and many forms of online commerce and communication that depend on it, may be on the brink of a “cryptopalypse” resulting from the collapse of decades-old methods of shared encryption.Read More >> Continue reading Data PRivacy Problems Kill Internet?

Solar Chargers in NYC's Parks
After Superstorm Sandy left so many New Yorkers without power, New York City and phone provider AT&T partner to install 25 solar powered charging stations over the summerRead More >> Continue reading Solar Chargers in NYC's Parks

Cyber Crime: Tablets are Dangerous?
Smartphone and tablet users are unwittingly sharing their personal data with strangers, including cyber criminals who could use it to go on an online buying spree, police warn.Read More >> Continue reading Cyber Crime: Tablets are Dangerous?

Biotech Stocks in Focus: Biogen consolidates, Stock Rated High
Biogen Idec’s (BIIB) shares were up slightly (0.62%) on the FDA approval of multiple sclerosis (MS) product, Plegridy (peginterferon beta-1a). The FDA approved Plegridy for the treatment of people with relapsing forms of multiple sclerosis (RMS). Plegridy Pen, a ready-to-use autoinjector, or a prefilled syringe can be used to administer Plegridy subcutaneously. Plegridy’s less frequent dosing schedule (once every two weeks) could help it gain … Continue reading Biotech Stocks in Focus: Biogen consolidates, Stock Rated High